Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 286 AL 300

Directed network motifs in Alzheimer's disease and mild cognitive impairment

Friedman EJ, Young K, Tremper G, Liang J, Landsberg AS, Schuff N; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2015 Apr 16;10(4):e0124453. doi: 10.1371/journal.pone.0124453. eCollection 2015.

Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update

Bradley-Whitman MA, Lovell MA.

Arch Toxicol. 2015 Jul;89(7):1035-44. doi: 10.1007/s00204-015-1517-6. Epub 2015 Apr 18.

Equivalence of kernel machine regression and kernel distance covariance for multidimensional phenotype association studies

Hua WY, Ghosh D.

Biometrics. 2015 Sep;71(3):812-20. doi: 10.1111/biom.12314. Epub 2015 May 1.

Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans

Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL, Ramanan VK, Foroud TM, Faber KM, Sarwar N, Munsie LM, Hu X, Soares HD, Potkin SG, Thompson PM, Kauwe JS, Kaddurah-Daouk R, Green RC, Toga AW, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):792-814. doi: 10.1016/j.jalz.2015.05.009.

Clearance systems in the brain-implications for Alzheimer disease

Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, de Leon MJ.

Nat Rev Neurol. 2015 Aug;11(8):457-70. doi: 10.1038/nrneurol.2015.119. Epub 2015 Jul 21.

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

Palmqvist S, Zetterberg H, Mattsson N, Johansson P; Alzheimer's Disease Neuroimaging Initiative; Minthon L, Blennow K, Olsson M, Hansson O; Swedish BioFINDER Study Group.

Neurology. 2015 Oct 6;85(14):1240-9. doi: 10.1212/WNL.0000000000001991. Epub 2015 Sep 9.

Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease

Lee SL, Thomas P, Fenech M.

Mutat Res. 2015 Jun;776:54-83. doi: 10.1016/j.mrfmmm.2014.12.012. Epub 2015 Jan 17.

Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject

Tiepolt S, Patt M, Hoffmann KT, Schroeter ML, Sabri O, Barthel H.

J Alzheimers Dis. 2015;47(3):539-43. doi: 10.3233/JAD-150163.

A Novel Plasma Based Biomarker of Alzheimer's Disease

Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA.

J Alzheimers Dis. 2015;47(3):761-71. doi: 10.3233/JAD-150183.

Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population

Xiao Q, Liu ZJ, Tao S, Sun YM, Jiang D, Li HL, Chen H, Liu X, Lapin B, Wang CH, Zheng SL, Xu J, Wu ZY.

Oncotarget. 2015 Nov 10;6(35):36955-64. doi: 10.18632/oncotarget.6271.

Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology

Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, Macaulay SL, Wilson W, Darby DG, Martins RN, Ames D, Collins S, Silbert B, Masters CL, Doecke JD; AIBL Research Group.

Alzheimers Res Ther. 2015 Nov 19;7(1):71. doi: 10.1186/s13195-015-0157-7.

Alzheimer's disease: Unique markers for diagnosis & new treatment modalities

Aggarwal NT, Shah RC, Bennett DA.

Indian J Med Res. 2015 Oct;142(4):369-82. doi: 10.4103/0971-5916.169193.

The New Conceptualization of Alzheimer's Disease under the Microscope of Influential Definitions of Disease

Alexopoulos P, Kurz A.

Psychopathology. 2015;48(6):359-67. doi: 10.1159/000441327. Epub 2015 Nov 27.

Plasma 8-isoPGF2α and serum melatonin levels in patients with minimal cognitive impairment and Alzheimer disease

Sirin FB, Kumbul Doğuç D, Vural H, Eren I, Inanli I, Sütçü R, Delibaş N.

Turk J Med Sci. 2015;45(5):1073-7. doi: 10.3906/sag-1406-134.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias